Glucovance

Glucovance is a brand name of glyburide/metformin, approved by the FDA in the following formulation(s):

GLUCOVANCE (glyburide; metformin hydrochloride - tablet; oral)

• 
  Manufacturer: BRISTOL MYERS SQUIBB
  
  Approval date: July 31, 2000
  
  Strength(s): 1.25MG;250MG ^[AB], 2.5MG;500MG ^[RLD][AB], 5MG;500MG ^[AB]

Has a generic version of Glucovance been approved?

A generic version of Glucovance has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Glucovance and have been approved by the FDA:

GLYBURIDE AND METFORMIN HYDROCHLORIDE (glyburide; metformin hydrochloride tablet; oral)

• 
  Manufacturer: ACTAVIS ELIZABETH
  
  Approval date: June 28, 2005
  
  Strength(s): 1.25MG;250MG ^[AB], 2.5MG;500MG ^[AB], 5MG;500MG ^[AB]


• 
  Manufacturer: AUROBINDO PHARMA
  
  Approval date: November 14, 2007
  
  Strength(s): 1.25MG;250MG ^[AB], 2.5MG;500MG ^[AB], 5MG;500MG ^[AB]


• 
  Manufacturer: COREPHARMA
  
  Approval date: November 19, 2004
  
  Strength(s): 1.25MG;250MG ^[AB], 2.5MG;500MG ^[AB], 5MG;500MG ^[AB]


• 
  Manufacturer: DR REDDYS LABS INC
  
  Approval date: June 3, 2009
  
  Strength(s): 1.25MG;250MG ^[AB], 2.5MG;500MG ^[AB], 5MG;500MG ^[AB]


• 
  Manufacturer: IVAX SUB TEVA PHARMS
  
  Approval date: February 18, 2004
  
  Strength(s): 1.25MG;250MG ^[AB], 2.5MG;500MG ^[AB], 5MG;500MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Glucovance. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Solid oral dosage form comprising a combination of metformin and glibenclamide
  Patent 6,303,146
  Issued: October 16, 2001
  Inventor(s): Bonhomme; Yves & Nicholson; Geoffrey & Cave; Gillian & Nicholson; Sarah J.
  Assignee(s): LIPHA
  The present invention relates to a solid oral dosage form comprising a combination of metformin and glibenclamide in which the size of glibenclamide is such that the glibenclamide bioavailability is comparable to the glibenclamide bioavailability obtained with a separate administration of metformin and glibenclamide.
  
  Patent expiration dates:
  
  
  • July 14, 2019
    
    ✓ 
    Patent use: TREATMENT OF TYPE 2 DIABETES
  
  
  
  • January 14, 2020
    
    ✓ 
    Patent use: TREATMENT OF TYPE 2 DIABETES
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Glucovance Consumer Information (Drugs.com)
• Glucovance Consumer Information (Wolters Kluwer)
• Glucovance Consumer Information (Cerner Multum)
• Glucovance Advanced Consumer Information (Micromedex)
• Glyburide/Metformin Consumer Information (Wolters Kluwer)
• Glyburide and metformin Consumer Information (Cerner Multum)
• Glyburide and metformin Advanced Consumer Information (Micromedex)